```html

Gamma‑hydroxybutyrate (GHB) Intoxication – A Comprehensive Medical Guide

Overview

Gamma‑hydroxybutyrate (GHB) is a central‑acting depressant that occurs naturally in the brain in trace amounts. When taken in larger quantities it produces euphoria, disinhibition, and profound sedation. Because of these effects, non‑prescribed GHB is used recreationally and, unfortunately, it is also implicated in drug‑facilitated sexual assaults (“date‑rape” drug).

GHB intoxication refers to the clinical syndrome that results from acute excessive ingestion—whether the product is the pharmaceutical formulation (e.g., Xyrem® for narcolepsy) or an illicit powder/liquid. The condition can affect anyone who uses GHB, but the highest‑risk groups are:

• Young adults aged 18‑30 who attend parties, clubs, or raves.
• Individuals with a history of substance use disorder.
• People prescribed sodium oxybate (Xyrem) who misuse the medication.
• Victims of sexual assault where GHB is administered covertly.

While exact global prevalence is difficult to capture, the United Nations Office on Drugs and Crime (UNODC) estimates that over 2 million individuals worldwide have used GHB at least once in the past year, with a sharp rise in North America and Europe during the 2010s.<sup>UNODC 2022</sup> In the United States, the Drug Abuse Monitoring Program (DAMP) reported ≈ 12,000 emergency department (ED) visits annually for GHB exposure between 2015‑2020.<sup>CDC 2023</sup>

Symptoms

The onset of symptoms is rapid—usually within 15‑30 minutes after ingestion—and can be dose‑dependent. Below is a complete list of recognized clinical features, grouped by system.

Neurological/Central Nervous System

• Drowsiness or profound sedation – the hallmark of GHB overdose.
• Confusion and disorientation – patients may be unable to answer simple questions.
• Ataxia (loss of coordination) – stumbling, difficulty walking.
• Slurred speech – similar to alcohol intoxication.
• Seizures – uncommon but reported in high‑dose exposures.
• Coma – in severe cases, patients progress to a non‑responsive state.

Cardiovascular & Respiratory

• Bradycardia (slow heart rate) – may be accompanied by hypotension.
• Respiratory depression – shallow breathing, low oxygen saturation, a major cause of mortality.
• Hypotension – can lead to dizziness or fainting.

Gastrointestinal

• Nausea and vomiting – may be present early.
• Abdominal discomfort – rarely severe.

Psychiatric

• Euphoria or “high” – often described as “floaty” or “warm” feeling.
• Amnesia – especially retrograde amnesia for events that occurred after ingestion.
• Hallucinations – visual or tactile, generally at high doses.

Other

• Flushed skin – reddening of face and neck.
• Urinary incontinence – loss of bladder control.
• Hyperthermia or hypothermia – extremes of body temperature have been documented.

Causes and Risk Factors

How intoxication occurs

GHB can be ingested orally, inhaled as a vapor, or absorbed through mucous membranes (e.g., when the liquid is “spiked” in a drink). The drug is highly water‑soluble, allowing rapid absorption from the gastrointestinal tract.

Key risk factors

• Polysubstance use – alcohol, benzodiazepines, or opioids synergistically depress the CNS, dramatically raising overdose risk.
• High‑dose “recreational” use – typical recreational doses range from 1–3 g; severe intoxication often occurs above 5 g.
• Prescription misuse – patients with narcolepsy may take extra doses of sodium oxybate for its euphoric effects.
• Young age – adolescents may underestimate potency because GHB’s colorless, odorless liquid resembles “energy drinks.”
• Co‑existing medical conditions – liver disease, chronic respiratory disease, or cardiac conduction abnormalities increase susceptibility to fatal outcomes.

Diagnosis

Diagnosis relies on a combination of clinical suspicion, patient history, and targeted investigations. Because GHB has a short half‑life (≈30–60 minutes), laboratory confirmation can be challenging if samples are not obtained promptly.

History and Physical Examination

• Timely questioning about recent party attendance, known drug use, or possible “spiking” of drinks.
• Document vital signs: respiratory rate, pulse, blood pressure, temperature, oxygen saturation.
• Neurological exam focusing on level of consciousness (Glasgow Coma Scale) and motor response.

Laboratory Tests

• Blood GHB level – measured by gas chromatography–mass spectrometry (GC‑MS) or liquid chromatography‑tandem mass spectrometry (LC‑MS/MS). Levels > 10 mg/L are generally considered toxic.<sup>J. Clin Toxicol 2013</sup>
• Blood alcohol concentration (BAC) – to assess co‑intoxication.
• Electrolytes, liver function tests, renal profile – for baseline organ status.
• Urine toxicology screen – may detect GHB if collected within 6 hours of exposure; many standard screens miss it, so a specific assay is required.

Imaging

Neuroimaging is not routinely indicated unless there is concern for head trauma, stroke, or seizure‑related complications. A CT head may be performed in comatose patients to rule out structural lesions.

Treatment Options

Management is primarily supportive, focusing on airway protection, ventilation, and hemodynamic stability. No specific antidote for GHB exists.

Immediate Emergency Care

• Airway management – Endotracheal intubation for patients with a Glasgow Coma Scale ≤ 8 or inadequate respiratory effort.
• Ventilatory support – Mechanical ventilation with 100 % oxygen; monitor end‑tidal CO₂.
• Intravenous fluids – Isotonic crystalloid bolus (20 mL/kg) to treat hypotension.
• Monitoring – Continuous cardiac telemetry, pulse oximetry, and frequent blood pressure checks.

Pharmacologic Interventions

• Benzodiazepines (e.g., lorazepam 1‑2 mg IV) – used to treat seizures or severe agitation; they do not reverse respiratory depression but can prevent seizures.
• Flumazenil – NOT indicated; it can precipitate seizures in a mixed overdose.
• Activated charcoal – May be considered if the patient presents within 30‑60 minutes and has a protected airway; evidence is limited.

Observation Period

Because GHB’s effects typically resolve within 3–4 hours, most patients are observed for at least 6 hours after the last known exposure. Those with prolonged sedation, co‑intoxication, or underlying medical disease may require longer monitoring.

Long‑Term Management & Lifestyle

• Referral to an addiction specialist for individuals with recurrent non‑prescribed use.
• Psychosocial counseling, motivational interviewing, and outpatient drug‑free programs.
• For prescription users (narcolepsy), education on proper dosing and secure storage of sodium oxybate.

Living with Gamma‑hydroxybutyrate (GHB) intoxication

While the term “living with intoxication” can sound alarming, most people who experience a single acute episode recover fully with no lasting organ damage. However, the following strategies help prevent recurrence and support overall health.

• Understand triggers – Recognize social situations where GHB may be offered and plan alternative activities.
• Secure medications – Keep any prescribed sodium oxybate in a locked container; never share it.
• Buddy system – When attending events where substances may be present, stay with a trusted friend who can watch for signs of overdose.
• Stay hydrated and eat – An empty stomach accelerates GHB absorption.
• Limit alcohol – Even modest amounts of alcohol synergistically increase GHB’s depressant effect.
• Seek counseling – If you notice cravings or repeated use, professional help can address underlying mental‑health issues.

Prevention

Prevention hinges on education, safe prescribing practices, and community awareness.

Individual‑level measures

• Read medication labels carefully; never exceed the prescribed dose of sodium oxybate.
• Never accept drinks from strangers; watch your beverage being prepared.
• Use drug‑checking services (where legal) to verify the purity of substances before use.

Community and policy measures

• Educational campaigns on college campuses about the risks of “date‑rape” drugs.
• Regulation of precursor chemicals (gamma‑butyrolactone, 1,4‑butanediol) that are metabolized to GHB.
• Training for first responders on the recognition and management of GHB overdose.

Complications

If not promptly recognized and treated, GHB intoxication can lead to serious, sometimes irreversible, sequelae.

• Respiratory arrest – Primary cause of death in severe overdose.
• Cardiac arrhythmias – Bradyarrhythmias or asystole secondary to hypoxia.
• Hypoxic brain injury – Prolonged oxygen deprivation may cause cognitive deficits.
• Traumatic injuries – Falls, motor‑vehicle accidents, or self‑inflicted injuries while impaired.
• Psychiatric sequelae – Post‑traumatic stress disorder (PTSD) in victims of drug‑facilitated sexual assault.
• Dependence & withdrawal – Chronic users develop tolerance; abrupt cessation can cause insomnia, anxiety, tremor, and, in severe cases, delirium.<sup>Addict Behav 2017</sup>

When to Seek Emergency Care

```